Search PubMedSearch

PubMed · 2187613

Studies in human models.

Abstract

Advances in the development of oral rehydration solutions (ORS) for the treatment of diarrheal disease depend on a knowledge of the disease process itself and of the factors that determine the movement of water and solutes across the gut. The formulation of ORS in current use is based on information derived from a number of different experimental approaches that attempt to take account of these factors. The fate of orally ingested solutions depends first on the processes of gastric emptying that control the rate of entry of fluid to the small intestine and second on the rates of absorption and secretion in the intestine. In the absence of a model that can reliably assess the effects of these two processes together, they are normally investigated separately. The methods of choice for measurement of gastric emptying are gamma scintigraphy and gastric aspiration. Multi-lumen perfusion techniques permit measurement of net flux in short segments of intestine. A promising new technique that takes account of both gastric emptying and intestinal transport involves measurement of accumulation in the circulation of isotopic tracers for water added to ingested solutions. The efficacy of new solutions must, however, ultimately be assessed in clinical trials on patients.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R J Maughan, J B Leiper. 1990. Studies in human models.. https://pubmed.ncbi.nlm.nih.gov/2187613/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Sodium restriction versus daily maintenance replacement in very low birth weight premature neonates: a randomized, blind therapeutic trial.

To test the hypothesis that restriction of sodium intake during the first 3 to 5 days of life will prevent the occurrence of hypernatremia and the need for administration of large fluid volumes, we prospectively and randomly assigned 17 babies (mean +/- SD: 850 +/- 120 gm; 27 +/- 1 weeks of gestation) to receive in blind fashion either daily maintenance sodium or salt restriction with physician-prescribed parenteral fluid intake. Maintenance-group infants received 3 to 4 mEq of sodium per kilogram per day; restricted infants received no sodium supplement other than with such treatments as transfusion. Sodium balance studies conducted for 5 days demonstrated that maintenance salt intake resulted in a daily sodium balance near zero, whereas sodium-restricted infants continued to excrete urinary sodium at a high rate, which promoted a more negative balance (average daily sodium balance -0.30 +/- 1.78 SD in maintenance group vs -3.71 +/- 1.47 mEq/kg per day in restriction group; p less than 0.001). Care givers tended to prescribe daily increases in parenteral fluids for the salt-supplemented infants, perhaps because serum sodium concentrations were elevated in these infants after the first day of the study (p less than 0.001). Hypernatremia developed in two sodium-supplemented infants (greater than 150 mEq/L), and hyponatremia developed in two sodium-restricted infants (less than 130 mEq/L); however, the restricted infants were more likely to have normal serum osmolality (p less than 0.05). Both groups of infants produced urine that was neither concentrated nor dilute, with a high fractional excretion of sodium; renal failure was not observed. The mortality rate was not affected, but the incidence of bronchopulmonary dysplasia was significantly less in the sodium-restricted babies (p less than 0.02). We conclude that in tiny premature infants, a fluid regimen that restricts sodium may simplify parenteral fluid therapy targeted to prevent hypernatremia and excessive administration of parenteral fluids.

Fluid Therapy